Predictors and outcomes of recurrent stent thrombosis: Results from a multicenter registry

JACC: Cardiovascular Interventions

Volumn 7, Issue 10, 2014, Pages 1105-1113

  Armstrong, Ehrin J ^a   Sab, Shiv ^b   Singh, Gagan D ^b   Lim, Wayland ^b   Yeo, Khung Keong ^b,c   Waldo, Stephen W ^d   Patel, Mitul ^e   Reeves, Ryan ^e   Macgregor, John S ^f   Low, Reginald I ^b   Shunk, Kendrick A ^f,g   Mahmud, Ehtisham ^e   Rogers, Jason H ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEPARTMENT OF CARDIOLOGY   (Singapore)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

angiography; recurrent stent thrombosis; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CREATINE KINASE; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; PRESCRIPTION DRUG; THIENOPYRIDINE DERIVATIVE; TICAGRELOR;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BLOOD VESSEL DIAMETER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PREDICTOR VARIABLE; RECURRENCE RISK; RECURRENT DISEASE; REGISTER; STENT THROMBOSIS; TEACHING HOSPITAL; UNITED STATES; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY THROMBOSIS; DEVICES; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RISK FACTOR; STENT; TIME; TREATMENT OUTCOME;

AGE FACTORS; AGED; CALIFORNIA; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908214339     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.05.017     Document Type: Article

References (40)

1. E.J. Armstrong, D.N. Feldman, and T.Y. Wang Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis J Am Coll Cardiol Intv 5 2012 131 140
2. J.W. van Werkum, A.A. Heestermans, and F.I. de Korte Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases Circulation 119 2009 828 834
3. M. Almalla, J. Schröder, V. Hennings, N. Marx, and R. Hoffmann Long-term outcome after angiographically proven coronary stent thrombosis Am J Cardiol 111 2013 1289 1294
4. T. Kimura, T. Morimoto, and K. Kozuma Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the registry of stent thrombosis for review and reevaluation Circulation 122 2010 52 61
5. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
6. P. Genereux, G.W. Stone, and R.A. Harrington Impact of intra-procedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION-PHOENIX trial J Am Coll Cardiol 63 2014 619 629
7. D.R. Holmes Jr., D.J. Kereiakes, and S. Garg Stent thrombosis J Am Coll Cardiol 56 2010 1357 1365
8. Y.L. Han, Q.Y. Zhang, Y. Li, and S.Y. Guan Clinical presentations, antiplatelet strategies and prognosis of patients with stent thrombosis: an observational study of 140 patients PLoS One 7 2012 e48520
9. I. Porto, F. Burzotta, and A. Parma Angiographic predictors of recurrent stent thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST]) Am J Cardiol 105 2010 1710 1715
10. G. Lemesle, A. Sudre, and T. Modine High incidence of recurrent stent thrombosis after successful treatment of a first in stent thrombosis Catheter Cardiovasc Interv 72 2008 470 478
11. D.E. Cutlip, S. Windecker, R. Mehran Academic Research C Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
12. K.K. Yeo, E. Mahmud, and E.J. Armstrong Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry Catheter Cardiovasc Interv 79 2012 550 556
13. C.M. Gibson, J.A. de Lemos, and S.A. Murphy Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation 103 2001 2550 2554
14. C.M. Gibson, C.P. Cannon, and S.A. Murphy Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 101 2000 125 130
15. C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
16. P. Genereux, T. Palmerini, and A. Caixeta Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX score J Am Coll Cardiol 59 2012 2165 2174
17. G.D. Dangas, B.E. Claessen, and R. Mehran Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes J Am Coll Cardiol Intv 5 2012 1097 1105
18. E.J. Armstrong, K.K. Yeo, and U. Javed Angiographic stent thrombosis at coronary bifurcations: short- and long-term prognosis J Am Coll Cardiol Intv 5 2012 57 63
19. A.J. Saltzman, R. Mehran, and G.D. Dangas Safety issues related to treating bifurcation lesions Rev Cardiovasc Med 11 Suppl 1 2010 S3 S10
20. G. Nakazawa, S.K. Yazdani, A.V. Finn, M. Vorpahl, F.D. Kolodgie, and R. Virmani Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation J Am Coll Cardiol 55 2010 1679 1687
21. K. Yunoki, T. Naruko, and T. Inoue Relationship of thrombus characteristics to the incidence of angiographically visible distal embolization in patients with ST-segment elevation myocardial infarction treated with thrombus aspiration J Am Coll Cardiol Intv 6 2013 377 385
22. E.J. Armstrong, A.T. Kwa, and K.K. Yeo Angiographically confirmed stent thrombosis in contemporary practice: insights from intravascular ultrasound Catheter Cardiovasc Interv 81 2013 782 790
23. I. Varghese, A. Ummer, M. Roesle, S. Banerjee, and E.S. Brilakis Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy Cardiovasc Revasc Med 9 2008 179 181
24. D.Y. Lee, J.P. Park, and S.J. Ko Recurrent very late stent thrombosis in a systemic lupus erythematous patient Korean Circ J 42 2012 118 121
25. E.H. Middlebrooks, and M. Panda Multiple recurrent stent thrombosis in a patient with coexisting clopidogrel resistance and increased anticardiolipin antibodies: a case report Case Rep Med 2010 2010 974149
26. M.K. Freynhofer, V. Bruno, and I. Brozovic Is increased platelet turnover responsible for low responsiveness to different thienopyridienes? A case report of recurrent stent thromboses Thromb Haemost 106 2011 1824
27. S.W. Waldo, E.J. Armstrong, and K.K. Yeo Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis Catheter Cardiovasc Interv 82 2013 1048 1053
28. K.D. Mahmoud, P.J. Vlaar, A.F. van den Heuvel, H.L. Hillege, F. Zijlstra, and B.J. de Smet Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis Am J Cardiol 108 2011 1721 1727
29. P.G. Steg, R.A. Harrington, H. Emanuelsson PLATO Study Group Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial Circulation 128 2013 1055 1065
30. S.D. Wiviott, E. Braunwald, C.H. McCabe TRITON-TIMI 38 Investigators Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
31. C.M. Gibson, A.K. Chakrabarti, J. Mega ATLAS-ACS 2 TIMI 51 Investigators Reduction of stent thrombosis in patients with acute coronary syndromes treated withrivaroxaban in ATLAS-ACS 2 TIMI 51 J Am Coll Cardiol 62 2013 286 290
32. T.L. Pinto Slottow, L. Bonello, and R. Gavini Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis Am J Cardiol 104 2009 525 530
33. H.J. Bouman, J.W. van Werkum, N.J. Breet, H. ten Cate, C.M. Hackeng, and J.M. ten Berg A case-control study on platelet reactivity in patients with coronary stent thrombosis J Thromb Haemost 9 2011 909 916
34. N. Sambu, A. Radhakrishnan, and H. Dent Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry Heart 98 2012 706 711
35. G.W. Stone, B. Witzenbichler, G. Weisz ADAPT-DES Investigators Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicenter registry study Lancet 382 2013 614 623
36. J.P. Collet, T. Cuisset, G. Rangé ARCTIC Investigators Bedside monitoring to adjust antiplatelet therapy for coronary stenting N Engl J Med 367 2012 2100 2109
37. M.J. Price, P.B. Berger, P.S. Teirstein GRAVITAS Investigators Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
38. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
39. T. Palmerini, A.J. Kirtane, and P.W. Serruys Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials Circ Cardiovasc Interv 5 2012 357 364
40. F. Philip, S. Agarwal, and M. Bunte Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous intervention trials in ST-segment elevation myocardial infarction Circ Cardiovasc Interv 7 2014 49 61